Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;35(1-2):1-22.
doi: 10.1159/000345791. Epub 2013 Jan 9.

A review: treatment of Alzheimer's disease discovered in repurposed agents

Brian S Appleby  1 , Dimitrios Nacopoulos, Nicholas Milano, Kate Zhong, Jeffrey L Cummings
Affiliations
Review

A review: treatment of Alzheimer's disease discovered in repurposed agents

Brian S Appleby et al. Dement Geriatr Cogn Disord. 2013.

Abstract

Background/aims: Many compounds that have already been approved for alternate diagnoses have been studied in relation to Alzheimer's disease (AD). The purpose of this review is to summarize these studies and discuss the rationale and benefits of repurposing drugs for AD treatment.

Methods: Studies of drugs related to AD treatment that were relevant to a disease-modifying mechanism of action (MOA) and are already approved by the Food and Drug Administration for non-AD diagnoses were collected from PubMed.

Results: Many drugs already approved for the treatment of other diseases have been studied in relation to AD treatment. Numerous drugs with known toxicity profiles have the potential to be repurposed as a treatment for AD.

Conclusion: Known MOA, toxicology, and pharmacodynamic profiles would accelerate the process and increase the odds of finding a more timely disease-modifying treatment for AD.

PubMed Disclaimer

MeSH terms